Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases

This study is currently recruiting participants.

Verified by University Health Network, Toronto, October 2005

First Received: October 18, 2005 Last Updated: November 29, 2005 History of Changes

Sponsored by:	University Health Network, Toronto
Information provided by:	University Health Network, Toronto
ClinicalTrials.gov Identifier:	NCT00242086

Purpose

The purpose of this study is to correlate the MRI CT and PET appearances of colorectal liver metastases to pathologic appearance ot better understand the accuracy of imaging to determine tumor size.

Condition	Intervention
Liver Metastases Colorectal Cancer	Procedure: CT, PET and MRI

Study Type:	Interventional
Study Design:	Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment
Official Title:	Comparison of Triphasic CT, CT/PET and MR Defined Gross Tumour With Pathological Findings in Patients With Colorectal Cancer Liver Metastases

Resource links provided by NLM:

MedlinePlus related topics: Cancer Colorectal Cancer

U.S. FDA Resources

Further study details as provided by University Health Network, Toronto:

Study Start Date:	October 2004
Estimated Study Completion Date:	January 2006

Detailed Description:

The purpose of this study is to correlate the MRI CT and PET appearances of colorectal liver metastases to pathologic appearance ot better understand the accuracy of imaging to determine tumor size.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

liver metastases from colorectal cancer undergoing liver resection

Exclusion Criteria:

contraindication to CT, MRI or PET

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00242086

Contacts

Contact: Masoom Haider, MD

416-946-4501 ext 4833

m.haider@utoronto.ca

Locations

Canada, Ontario
University Health Network, Princess Margaret Hospital	Recruiting
Toronto, Ontario, Canada, M5G 2M9
Contact: Masoom Haider, MD 416 946 4501 ext 4833 m.haider@utoronto.ca

Sponsors and Collaborators

University Health Network, Toronto

Investigators

Principal Investigator:

Masoom Haider, MD

University Health Network, Toronto

More Information

No publications provided

Study ID Numbers:	04-0659-C
Study First Received:	October 18, 2005
Last Updated:	November 29, 2005
ClinicalTrials.gov Identifier:	NCT00242086 History of Changes
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Liver Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms

Liver Neoplasms
Signs and Symptoms
Digestive System Diseases
Neoplasm Metastasis
Gastrointestinal Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:

Liver Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Liver Neoplasms

Neoplastic Processes
Neoplasms
Pathologic Processes
Neoplasms by Site
Digestive System Diseases
Neoplasm Metastasis
Gastrointestinal Neoplasms
Colorectal Neoplasms

ClinicalTrials.gov processed this record on September 10, 2009